13D/13G Filings - SCILEX HLDG CO WT EXP (SCLXW)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-01-23
9:21 pm
Sale
2025-01-2113DScilex Holding Company
SCLX
SCLX Stock Acquisition JV LLC80,586,928
21.100%
-4,029,371decrease
(-4.76%)
Filing
History
2025-01-17
4:15 pm
Purchase
2025-01-1313GScilex Holding Company
SCLX
ORAMED PHARMACEUTICALS INC.
ORMP
15,500,000
6.200%
15,500,000increase
(New Position)
Filing
History
2025-01-06
7:11 pm
Sale
2025-01-0213DScilex Holding Company
SCLX
SCLX Stock Acquisition JV LLC84,616,299
22.800%
-5,000,000decrease
(-5.58%)
Filing
History
2024-09-09
4:11 pm
Purchase
2024-08-3013DDenali Capital Acquisition Corp.
DECA
Scilex Holding Co
SCLX
500,000
39.900%
500,000increase
(New Position)
Filing
History
2024-04-25
5:25 pm
Unchanged
2024-04-2513DScilex Holding Company
SCLX
SCLX Stock Acquisition JV LLC89,616,299
33.300%
0
(Unchanged)
Filing
History
2024-03-05
4:22 pm
Unchanged
2024-03-0513DScilex Holding Company
SCLX
SCLX Stock Acquisition JV LLC89,616,299
36.400%
0
(Unchanged)
Filing
History
2024-01-31
5:24 pm
Unchanged
2023-11-3013DScilex Holding Company
SCLX
SCLX Stock Acquisition JV LLC89,616,299
38.200%
0
(Unchanged)
Filing
History
2023-09-29
4:15 pm
Purchase
2023-09-2113DScilex Holding Company
SCLX
SCLX Stock Acquisition JV LLC89,616,299
39.300%
89,616,299increase
(New Position)
Filing
History
2023-09-26
4:49 pm
Sale
2023-09-2113DScilex Holding Company
SCLX
Sorrento Therapeutics Inc.
SRNEQ
1,917,210
1.300%
-93,616,299decrease
(-97.99%)
Filing
History
2023-08-14
8:59 pm
Unchanged
2023-08-0713DScilex Holding Company
SCLX
Sorrento Therapeutics Inc.
SRNEQ
95,533,509
43.300%
0
(Unchanged)
Filing
History
2023-03-03
09:10 am
Unchanged
2023-02-2113DScilex Holding Company
SCLX
Sorrento Therapeutics Inc.
SRNEQ
95,533,509
44.200%
0
(Unchanged)
Filing
History
2023-02-13
1:52 pm
Unchanged
2022-12-3113GScilex Holding Company
SCLX
Hudson Bay Capital Management LP0
0.000%
0
(Unchanged)
Filing
History
2023-01-23
4:33 pm
Sale
2023-01-1913DScilex Holding Company
SCLX
Sorrento Therapeutics Inc.
SRNEQ
95,533,509
45.500%
-72,354,178decrease
(-43.10%)
Filing
History
2022-12-09
4:21 pm
Sale
2022-11-3013GVickers Vantage Corp. I
VCKA
KARPUS MANAGEMENT, INC.0
0.000%
-1,737,145decrease
(Position Closed)
Filing
History
2022-11-17
5:09 pm
Purchase
2022-11-1013DScilex Holding Company
SCLX
Sorrento Therapeutics Inc.
SRNEQ
167,887,687
96.300%
167,887,687increase
(New Position)
Filing
History
2022-11-14
09:14 am
Sale
2022-11-0913GVickers Vantage Corp. I
VCKA
Feis Lawrence0
0.000%
-753,037decrease
(Position Closed)
Filing
History
2022-07-27
3:33 pm
Purchase
2022-07-2613GVickers Vantage Corp. I
VCKA
Feis Lawrence753,037
5.720%
753,037increase
(New Position)
Filing
History
2022-02-14
3:28 pm
Purchase
2021-12-3113GVickers Vantage Corp. I
VCKA
CVI Investments, Inc.749,600
4.300%
749,600increase
(New Position)
Filing
History
2022-02-11
2:19 pm
Purchase
2021-12-3113GVickers Vantage Corp. I
VCKA
Shaolin Capital Management LLC1,325,779
7.700%
1,325,779increase
(New Position)
Filing
History
2022-02-03
4:55 pm
Purchase
2021-12-3113GVickers Vantage Corp. I
VCKA
Hudson Bay Capital Management LP900,500
5.220%
900,500increase
(New Position)
Filing
History
Goto 0, 1, Next